Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and safety assurance than ever before. Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational Integration Site […]

New optimizations increase yields up to 5x, accelerate workflows by more than 35% and reduce sample preparation costs by up to 30%  BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced a new optimized Bead Booster chemistry […]

Oxford Nanopore’s devices with 4bases kits will enable decentralised, flexible scalability with a significant decrease in turnaround time for clinical researchers in Italy and Switzerland, with a first target of same-day BRCA1 and BRCA2 analysis. Oxford Nanopore Technologies plc (Oxford Nanopore) and 4bases, a Switzerland-based company, specialising in kits for sequencing and bioinformatic tools, today announce […]

BOSTON — Stilla Technologies, the multiplex digital PCR company, has recently introduced the Ruby Chip, the industry’s first ‘load-and-go’ consumable for digital PCR, optimized for its naica® system. The naica® system, which now supports 21 CFR Part 11 regulatory compliance, is part of a fully-automated sample-to-results workflow – the first of its kind for digital PCR. This platform […]

Illumina’s plan will maximize shareholder value Illumina is engaged with regulators to define GRAIL’s path forward as expeditiously as possible Icahn’s director nominees do not add value to the Board and will damage Illumina’s core business SAN DIEGO — Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response […]

Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has entered into an agreement for Labcorp (NYSE: LH) to acquire the assets of Enzo’s Clinical Laboratory division (Enzo Clinical Labs). The transaction between two leading global life sciences companies follows several […]

INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time savings to academic, research and diagnostics laboratories using NGS and, ultimately, accelerating discovery in […]

Life sciences tools veteran brings decades of experience leading successful teams, commercializing industry-defining technology platforms, and scaling global organizations. MONHEIM AM RHEIN, Germany – Resolve Biosciences, a company pioneering Molecular Cartography™ technology, announced today that it has appointed John Stark as Chief Executive Officer. As part of this transition, Resolve Biosciences’ previous CEO, Jason Gammack, will […]

CARLSBAD, Calif. — Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput microbial WGS library preparation kit enabling 2nd-generation short-read sequencers to produce long-range results in a much affordable price for microbial genomes. With this special high throughput kit, users can pool more microbial samples […]

Enhanced usability to support PCR applications in basic and translational research, process development, and quality control  HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR […]